PharmaPoint: Rheumatoid Arthritis - India Drug Forecast And Market Analysis Event-Driven Update

Table 24: Key Events Impacting Sales for Rheumatoid Arthritis in India, 2012 62



Table 25: Rheumatoid Arthritis Market - Drivers and Barriers in India, 2012 63



Table 26: Key Launch Dates 75



Table 27: Key Patent Expiries 75



Table 28: Physicians Surveyed, By Country 81

List of Figures

Figure 1: Healthy and Arthritic Joint with Rheumatoid Arthritis 10



Figure 2: Rheumatoid Arthritis Biologic Drug Targets 12



Figure 3: Diagnosis Criteria for Rheumatoid Arthritis Based on 2010 ACR/EULAR Criteria Point System 17



Figure 4: Severity of Rheumatoid Arthritis 17



Figure 5: Biologic Treatment Flow Based on Updated 2012 ACR Treatment Recommendations* 20



Figure 6: Competitive Assessment of Late-Stage Pipeline Agents in RA, 2012-2022 59



Figure 7: Sales for Rheumatoid Arthritis in India by Drug Class 61

To order this report: Pathology Industry: PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis Event-Driven Update

__________________________

Nicolas BombourgReportlinkerEmail: [e-mail]: [phone]Intl: [phone]

 

 

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

« First ‹ Previous 1 2 3 4